Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2727-2729, July 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krett, N. L.
Right arrow Articles by Rosen, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krett, N. L.
Right arrow Articles by Rosen, S. T.

A Variant Glucocorticoid Receptor Messenger RNA Is Expressed in Multiple Myeloma Patients1

Nancy L. Krett2, Shafali Pillay, Pamela A. Moalli, Philip R. Greipp and Steven T. Rosen

Robert H. Lurie Cancer Center and Department of Medicine, Northwestern University, Chicago, Illinois 60611 [N. L. K., S. P., P. A. M., S. T. R.], and Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55905 [P. R. G.]

In multiple myeloma cells resistant to glucocorticoids, we have previously identified a variant glucocorticoid receptor (GR) transcript (P. A. Moalli et al., Cancer Res., 53: 3877–3879, 1993). Here, we report a reverse transcription-PCR assay to assess whether this aberrant GR transcript is present in myeloma patients. We detected both the wild-type and variant GR transcripts in the patient isolate that was the source of our myeloma cell lines, in patients refractory to steroid treatment, and in healthy control subjects. Simultaneous amplification of wild-type and variant GR mRNAs indicates that the variant GR is more highly expressed in cells that are resistant to glucocorticoids. We hypothesize that the variant GR is a normal mRNA transcript that acts to modulate glucocorticoid responsiveness, and increased expression contributes to a resistant phenotype.

1 This project was funded by the Eastern Cooperative Oncology Group, the American Cancer Society (Illinois Division), and National Cancer Institute Grant P30 CA60553-01 to the Robert H. Lurie Cancer Center.

2 To whom requests for reprints should be addressed, at Northwest University Medical Center, R. H. Lurie Cancer Center, 8340 Olson Pavilion, 303 East Chicago Avenue, Chicago, IL 60611.

Received 3/20/95. Accepted 5/19/95.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Flynn, S. D. Dimitrijevich, M. Younes, G. Skliris, L. C. Murphy, and P. R. Cammarata
Role of wild-type estrogen receptor-{beta} in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E637 - E647.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
H. Russcher, V. A S H Dalm, F. H de Jong, A. O Brinkmann, L. J Hofland, S. W J Lamberts, and J. W Koper
Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene
J. Mol. Endocrinol., January 1, 2007; 38(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Sanchez-Vega, N. Krett, S. T. Rosen, and V. Gandhi
Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells
Mol. Cancer Ther., December 1, 2006; 5(12): 3062 - 3070.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. C. Chikanza and D. L. Kozaci
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Rheumatology, November 1, 2004; 43(11): 1337 - 1345.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. R. Yudt and J. A. Cidlowski
The Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Mol. Endocrinol., August 1, 2002; 16(8): 1719 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. de Lange, C. M. Segeren, J. W. Koper, E. Wiemer, P. Sonneveld, A. O. Brinkmann, A. White, I. J. Brogan, F. H. de Jong, and S. W. J. Lamberts
Expression in Hematological Malignancies of a Glucocorticoid Receptor Splice Variant That Augments Glucocorticoid Receptor-mediated Effects in Transfected Cells
Cancer Res., May 1, 2001; 61(10): 3937 - 3941.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. E. Tome, A. F. Baker, G. Powis, C. M. Payne, and M. M. Briehl
Catalase-overexpressing Thymocytes Are Resistant to Glucocorticoid-induced Apoptosis and Exhibit Increased Net Tumor Growth
Cancer Res., March 1, 2001; 61(6): 2766 - 2773.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon
Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo
Cancer Res., April 1, 2000; 60(7): 2056 - 2062.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.